Graham Capital Management, L.P.

Position in BHC — Bausch Health Companies Inc.

CIK 1315421 ROWAYTON, CT

Back to BHC Full portfolio

Position in BHC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$502,717

+$48,604 QoQ

Shares Held

101,971

+21.3% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#80

of 220 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $4,664,055 across 12 Drug Manufacturers - Specialty & Generic names. BHC ranks #3 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	75,653	$1,212,717
2	HLN	Haleon plc	55,057	$513,681
3	BHC	Bausch Health Companies Inc. This page	101,971	$502,717
4	AMRX	Amneal Pharmaceuticals, Inc.	24,035	$416,045
5	PBH	Prestige Consumer Healthcare Inc.	7,136	$337,318
6	COLL	Collegium Pharmaceutical, Inc	8,555	$309,691
7	ZTS	Zoetis Inc.	4,304	$309,285
8	PRGO	PERRIGO Co plc	28,290	$293,933

All Filings in BHC

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$502,717	101,971	+21.3%	Shares	Sole	2026-08-14
2026-03-31	$454,113	84,095	-37.7%	Shares	Sole	2026-05-15
2025-12-31	$938,145	134,985	+189.4%	Shares	Sole	2026-02-17
2025-09-30	$300,892	46,650	+23.0%	Shares	Sole	2025-11-14
2025-06-30	$252,593	37,927	-87.7%	Shares	Sole	2025-08-14
2025-03-31	$1,990,197	307,604	+120.5%	Shares	Sole	2025-05-15
2024-12-31	$1,124,224	139,482	+435.1%	Shares	Sole	2025-02-14
2024-09-30	$212,690	26,065	-55.5%	Shares	Sole	2024-11-14
2024-03-31	$621,332	58,561	-26.6%	Shares	Sole	2024-05-15
2023-12-31	$640,212	79,827	+664.3%	Shares	Sole	2024-02-14
2023-06-30	$83,552	10,444	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.